Active, Not Recruiting
A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia
NCT01683279
- Conditions
- B Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- Seattle Children's Hospital Seattle, Washington, United States